- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Teladoc Inc (TDOC)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
01/09/2026: TDOC (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $9.15
1 Year Target Price $9.15
| 3 | Strong Buy |
| 2 | Buy |
| 19 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -21.42% | Avg. Invested days 34 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.35B USD | Price to earnings Ratio - | 1Y Target Price 9.15 |
Price to earnings Ratio - | 1Y Target Price 9.15 | ||
Volume (30-day avg) 24 | Beta 2.05 | 52 Weeks Range 6.35 - 15.21 | Updated Date 01/9/2026 |
52 Weeks Range 6.35 - 15.21 | Updated Date 01/9/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.26 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -8.84% | Operating Margin (TTM) -5.66% |
Management Effectiveness
Return on Assets (TTM) -3.48% | Return on Equity (TTM) -15.42% |
Valuation
Trailing PE - | Forward PE 357.14 | Enterprise Value 1666393612 | Price to Sales(TTM) 0.53 |
Enterprise Value 1666393612 | Price to Sales(TTM) 0.53 | ||
Enterprise Value to Revenue 0.66 | Enterprise Value to EBITDA 11.87 | Shares Outstanding 177473405 | Shares Floating 175487478 |
Shares Outstanding 177473405 | Shares Floating 175487478 | ||
Percent Insiders 1.01 | Percent Institutions 72.02 |
Upturn AI SWOT
Teladoc Inc

Company Overview
History and Background
Teladoc Health, Inc. was founded in 2002 by Byron L. Wood (CEO), Marcus D. Mosely (COO), and Michael J. Gorton (President) in New York City. Initially known as Teladoc, it pioneered telehealth services by offering remote medical consultations via phone and video. Key milestones include its IPO in 2015 and significant acquisitions like Livongo Health in 2020, which expanded its capabilities into chronic condition management. The company has evolved to offer a comprehensive suite of virtual care services, including mental health, chronic disease management, and expert medical opinions.
Core Business Areas
- Virtual Care Services: Provides on-demand and scheduled telehealth consultations with physicians and specialists for a wide range of medical needs, including general health, dermatology, mental health, and more. This is delivered through its proprietary platform.
- Chronic Condition Management: Leverages its acquisition of Livongo to offer programs for managing chronic conditions such as diabetes, hypertension, and weight management through connected devices, personalized insights, and coaching.
- Mental Health Services: Offers virtual therapy and psychiatry services through its BetterHelp platform, providing accessible and convenient mental health support.
- Expert Medical Services: Connects patients with leading specialists for second opinions on complex medical conditions, aiding in diagnosis and treatment planning.
Leadership and Structure
Teladoc Health is led by a senior executive team, with the CEO being the primary decision-maker. The company operates through various divisions focusing on its core service offerings, often integrated through its technology platform. Key leadership roles typically include CEO, CFO, Chief Medical Officer, and heads of product, technology, and market segments.
Top Products and Market Share
Key Offerings
- Competitors: Amwell (AMWL), Doctor on Demand, MDLIVE
- Description: Provides immediate access to healthcare professionals for urgent but non-emergency medical needs. This includes diagnosis, treatment recommendations, and prescriptions. Competitors include Amwell (AMWL), Doctor on Demand, MDLIVE. Market share data for individual product lines is not publicly disclosed but is a significant portion of the company's revenue. Estimated number of members served is in the tens of millions.
- Product Name 1: Teladoc On-Demand Virtual Care
- Competitors: Omada Health, Virta Health
- Description: Offers personalized programs for managing chronic conditions like diabetes and hypertension. Integrates connected devices (e.g., glucose meters, blood pressure cuffs) with data analytics and coaching. Competitors include Omada Health, Livongo (now part of Teladoc), Virta Health. Livongo was a significant player prior to acquisition.
- Product Name 2: Chronic Care Management (e.g., Livongo)
- Competitors: Talkspace, Cerebral
- Description: A leading online therapy platform connecting individuals with licensed therapists for private, convenient, and affordable mental health support via text, phone, or video. Competitors include Talkspace, Cerebral, and other online therapy platforms. While precise market share is hard to ascertain, it is a major player in the direct-to-consumer mental health space.
- Product Name 3: BetterHelp (Mental Health)
Market Dynamics
Industry Overview
The telehealth and virtual care industry is experiencing significant growth, driven by increasing consumer demand for convenient and accessible healthcare, technological advancements, and a growing acceptance by healthcare providers and payers. The COVID-19 pandemic significantly accelerated this adoption. The market is characterized by a mix of established healthcare players, technology companies, and specialized telehealth providers.
Positioning
Teladoc Health is a market leader in the telehealth industry, particularly strong in integrated virtual care solutions encompassing general health, chronic condition management, and mental health. Its key competitive advantages include its extensive network of providers, proprietary technology platform, and significant scale. The acquisition of Livongo has bolstered its chronic care capabilities, creating a more comprehensive offering.
Total Addressable Market (TAM)
The global telehealth market is substantial and projected to continue its rapid expansion, with estimates varying but generally reaching hundreds of billions of dollars in the coming years. Teladoc is positioned to capture a significant portion of this TAM through its broad service offerings and established partnerships with employers, health plans, and health systems.
Upturn SWOT Analysis
Strengths
- Market leadership position in telehealth.
- Comprehensive suite of virtual care services (general health, chronic care, mental health).
- Strong brand recognition and established provider network.
- Proprietary technology platform with integrated data analytics.
- Significant scale and reach through partnerships with employers and health plans.
Weaknesses
- Profitability challenges and ongoing investment in growth.
- Dependence on reimbursement policies and regulatory changes.
- Intensifying competition from traditional healthcare providers and new entrants.
- Integration challenges and potential dilution from large acquisitions like Livongo.
- Customer acquisition costs can be high.
Opportunities
- Continued growth in demand for virtual care services post-pandemic.
- Expansion into new international markets.
- Further integration of AI and data analytics for personalized care.
- Partnerships with healthcare systems for hybrid care models.
- Growth in demand for mental health services.
Threats
- Increasing competition and potential price wars.
- Changes in government regulations and reimbursement rates.
- Cybersecurity risks and data privacy concerns.
- Slower than expected adoption by certain patient demographics or provider groups.
- Economic downturns impacting employer-sponsored benefits.
Competitors and Market Share
Key Competitors
- Amwell (AMWL)
- Cerebral
- Doctor on Demand
- MDLIVE
- Talkspace
Competitive Landscape
Teladoc's advantages lie in its integrated platform, scale, and established relationships. However, competitors are strong in specific niches (e.g., BetterHelp's direct-to-consumer mental health focus versus Amwell's broader health system partnerships). Competition is intense, with players differentiating on technology, breadth of services, pricing, and provider network quality.
Major Acquisitions
Livongo Health
- Year: 2020
- Acquisition Price (USD millions): 18500
- Strategic Rationale: To significantly expand Teladoc's capabilities in chronic condition management, leveraging Livongo's data analytics and connected device technology to create a more comprehensive virtual care offering.
BetterHelp
- Year: 2019
- Acquisition Price (USD millions): 150
- Strategic Rationale: To bolster its mental health services segment, providing a leading direct-to-consumer platform for therapy and psychiatry, thereby addressing a rapidly growing segment of the virtual care market.
Growth Trajectory and Initiatives
Historical Growth: Teladoc has demonstrated significant historical growth, primarily driven by strategic acquisitions and the increasing adoption of telehealth services. Revenue has seen substantial year-over-year increases, especially following the Livongo acquisition. The company has consistently expanded its service offerings and member base.
Future Projections: Analyst projections for Teladoc's future growth typically anticipate continued revenue expansion, driven by its diversified service portfolio and market penetration. However, profitability projections often hinge on the company's ability to manage costs, achieve synergies from acquisitions, and navigate the competitive landscape. Forward-looking statements from the company and analyst reports would provide specific growth rate expectations.
Recent Initiatives: Recent initiatives have focused on integrating the Livongo acquisition, expanding mental health services, enhancing its chronic care platform, and pursuing international growth opportunities. The company is also investing in its technology to improve user experience and data analytics capabilities.
Summary
Teladoc Health is a pioneer and leader in the virtual care industry, offering a broad spectrum of services from on-demand doctor visits to chronic condition management and mental health support. The company benefits from strong market demand and a comprehensive platform. However, it faces challenges with profitability, intense competition, and the integration of its significant acquisitions. Continued investment in technology and strategic partnerships will be crucial for sustained success.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company SEC Filings (10-K, 10-Q)
- Financial News Outlets (e.g., Bloomberg, Reuters, Wall Street Journal)
- Analyst Reports
- Industry Research Firms
Disclaimers:
This JSON output is a structured overview of Teladoc Inc. based on publicly available information. It is intended for informational purposes only and does not constitute financial advice. Market share data and financial metrics are estimates and may vary depending on the source and reporting period. Investment decisions should be made after consulting with a qualified financial advisor and conducting independent research.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Teladoc Inc
Exchange NYSE | Headquaters Purchase, NY, United States | ||
IPO Launch date 2015-07-01 | CEO & Director Mr. Charles Divita III, CPA | ||
Sector Healthcare | Industry Health Information Services | Full time employees 4620 | Website https://www.teladochealth.com |
Full time employees 4620 | Website https://www.teladochealth.com | ||
Teladoc Health, Inc. provides virtual healthcare services worldwide. It operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counselling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

